The mechanism of HMGB1 in the pathogenesis of septic encephalopathy
| Project/Area Number |
23791728
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Anesthesiology/Resuscitation studies
|
|---|
| Research Institution | Teikyo University |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2011 – 2013
|
| Project Status |
Completed (Fiscal Year 2013)
|
| Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2013: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2012: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2011: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
|---|
| Keywords | 脳・神経 / 敗血症 / HMGB1 / 睡眠・覚醒 / MCH / 記憶 / 集中治療 / ＨＭＧＢ１ |
|---|
| Research Abstract |
We demonstrated that intracerebroventricular (icv) injection of HMGB1(High mobility group box 1) reduced awakening period, and increased the non-rapid eye movement episode time.We also demonstrated that icv injection of melanin-concentrating hormone(MCH) increased hippocampal acetylcholine release in both HMGB1 (pre-treatment) group and normal saline(pre-treatment) group. Icv injection of HMGB1 did not reduce the hippocampus acetylcholine release, and had no effect on hippocampal acetylcholine release after icv injection of MCH.
|
Report
(4 results)
Research Products
(2 results)
